November 30, 2010 Roger L. Williams, MD Chief Executive Officer U.S. Pharmacopeia Headquarters - Pyrimidine - Document - PDFSEARCH.IO

First Page	Meta Content
	November 30, 2010 Roger L. Williams, MD Chief Executive Officer U.S. Pharmacopeia Headquarters Add to Reading List Open Document File Size: 152,07 KB Share Result on Facebook Country United States / / Facility American College of Rheumatology / Pharmacopeia Headquarters / / MedicalCondition available gout / gout / fibromyalgia / inflammation / rheumatic diseases / Several gout / / Organization The American College / FDA / Medicare / / Person Karen S. Kolba / Roger L. Williams / / / Position Chief Executive Officer U.S. Pharmacopeia Headquarters / Chair / Committee / / ProvinceOrState Maryland / / SocialTag Uric acid Inborn errors of purine-pyrimidine metabolism Arthritis Fibromyalgia Pharmacology Gout Food and Drug Administration Non-steroidal anti-inflammatory drug United States Pharmacopeia Health

November 30, 2010 Roger L. Williams, MD Chief Executive Officer U.S. Pharmacopeia HeadquartersAdd to Reading List